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a b s t r a c t
Multivalent interactions play an essential role in molecular recognition in living systems. These effects
were employed to target tumor cells using albumin clusters bearing 10 molecules of asparagine-linked
glycans (N-glycans). Noninvasive near-infrared fluorescence imaging clearly revealed A431 tumors
implanted in BALB/cA-nu/nu mice after 1 h in an N-glycan structure-dependent manner, thereby demon-
strating the efficient use of glycan multivalency effects for tumor targeting in vivo.
 2016 Elsevier Ltd. All rights reserved.
A variety of strong ligand–receptor interactions, such as the
antigen–antibody and biotin–avidin interactions,1,2 have been
explored for their utility in medical and chemical biology applica-
tions. Relatively weak interactions can also play an important role
in ligand–receptor interactions in living systems. These interac-
tions are often strengthened by cluster effects: a single interaction
that is too weak to invoke a biological reaction may be bolstered by
forming ligand clusters that engage in multivalent interactions to
increase the overall interaction strength and initiate a biological
process. For example, the glycan–lectin interaction is relatively
weak, but these moieties may be clustered to play an indispensable
role in molecular recognition processes.3–6 The artificial introduc-
tion of glycan into a template can mimic clustered molecular
recognition to the benefit of biological studies.7–11 Since the
pioneering synthesis of glycopolymers by Whitesides,12 glycoclus-
ter strategies have been extensively studied. Significant multiva-
lency effects have been obtained among glycan dendrimers,
which act as anti-adhesion molecules,13–15 and among glycan-
coated liposomes, which act as drug delivery systems.16 Kato and
Fujita recently developed a novel self-assembled spherical
complex of gangliosides and characterized its interactions with
amyloid b and a-sinuclein.17
Our group has also investigated the in vivo profiles of glycoclus-
ters by synthesizing a polylysine-based N-glycan dendrimer.18 The
low stability of this dendrimer in serum resulted in rapid excretion
from the mouse body. To circumvent this problem, we developed
an efficient strategy for constructing N-glycan clusters on a protein
surface using a combination of strain-promoted alkyne–azide
cyclization19 and 6p-azaelectrocyclization20 reactions (Fig. 1).21
The N-glycans 2a–f were connected to the unsaturated aldehyde
1 linker to yield 3a–f, which were reacted with fluorescence-
labeled human serum albumin (HSA) 4 to afford the glycoalbumins
5a–f (Figs. 1 and 2). As many as ten N-glycans, both homogeneous
glycans and heterogeneous glycans, could be introduced onto a
single molecule of HSA in a few simple steps. The in vivo kinetics
of these glycans in nude mice depended strongly on the structure
of the N-glycan: a sialic acid-terminated glycocluster was excreted
via the urinary bladder, whereas a galactose-terminated glycoclus-
ter was selectively excreted via the intestines. The excretion path-
way could, therefore, be controlled by the glycan structure.
Microscopy studies revealed that the glucosamine-terminated gly-
coclusters were specifically localized in non-parenchymal cells in
the liver, which might find future use in the detection of liver cir-
rhosis. These results suggested that receptor-mediated molecular
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